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1078–5Background. Disordered programmed cell death may play a role in the development of superficial venous incompetence.
We have determined the number of cells in apoptosis, and the mediators regulating the intrinsic and extrinsic pathways in
specimens of varicose vein.
Methods. Venous segments were obtained from 46 patients undergoing surgical treatment for primary varicose veins.
Controls samples were obtained from 20 patients undergoing distal arterial bypass grafting surgery. Segments of the distal
and proximal saphenous trunk as well as tributaries were studied. Cell apoptoses and mediators of the mitochondrial and
trans membrane pathway were evaluated with peroxidase in situ apoptosis detection, Bax and Fas detection, caspase-9 and
8 detection in the medial layer.
Results. Disorganised histological architecture was observed in varicose veins. Primary varicose veins also contained fewer
peroxidase in situ-positive cells than control veins (2.6% S.D. 0.2% versus 12% S.D. 0.93%, P¼ .0001, Mann-Whitney u
test), fewer Bax positive cells (2.1.% S.D. 0.3% versus 13% S.D. 0.9%, P¼ .0001) and fewer Caspase 9 positive cells
(3.2% S.D. 1% versus 12% S.D. 1.3%, P¼ .0001). Similar findings were observed in saphenous trunk, main tributaries
and accessory veins. In patients with recurrent varicose veins in whom the saphenous trunk had been preserved showed
similar findings to primary varicose veins. Residual varicose veins contained fewer peroxidase in situ-positive cells than
healthy veins (3.2% S.D. 0.6% versus 11% S.D. 2%, P¼ .0001), fewer Bax positive cells (2.2% S.D. 0.3% versus
12% S.D. 0.7%, P¼ .0001) and fewer Caspase 9 positive cells (2.6% S.D. 0.6% versus 12% S.D. 1%, P¼.0001). Immu-
nohistochemical detection for Fas and caspase 8 remained equal was the same in the varicose vein and control groups.
Conclusion. Apoptosis is down regulated in the medial layer of varicose veins. This dysregulation is attributable to a dis-
order of the intrinsic pathway and involves the great saphenous vein trunk, major tributaries and accessory veins. This
process may be among the causes of primary varicose veins.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Current research indicates that dysregulation in the
number of parietal cells undergoing apoptosis in the
venous wall is important in the onset and progression
of human primary varicose veins.1e5 Studies in hu-
man renal, coronary and carotid arteries have shown
increased apoptosis and increased numbers of intrin-
sic pathway promotors including the apoptoticsponding author. Dr. E. Ducasse, Unit of vascular surgery,
al tripode-pellegrin, tripode 5e`me, 33076 Bordeaux, France.
address: eric.ducasse@online.fr
884/000224+ 06 $34.00/0  2007 Published by Elsevier Ltd onpromoter Bax.6 The apoptotic process is regulated by
specific activation of a family of intracellular cysteine
proteases knownas caspases (cysteine aspartyl-specific
proteases) inducible by various cellular and external
stimuli.7 Two regulatory pathways are recognised.
The intrinsic pathway (mitochondria pathway or type
I) is regulated by apoptosis promoter proteins [such
as Bax or Bcl-2] and involves specific caspases [espe-
cially caspase 9] along with the participation of mito-
chondria. The extrinsic pathway (trans-membrane
pathway or type II) is regulated by proteins [such as
fas, the tumour-necrosis factor receptor (TNF-R) family
proteins] and involves specific caspases [especiallybehalf of European Society for Vascular Surgery.
225Primary Varicose Veinscaspase 8] connecting ligand binding at the cell surface
to apoptosis induction.8e11 Apoptotic dysregulation in
the superficial vein wall of varicose veins is mediated
via the intrinsic pathway. This involves the whole sa-
phenous vein independently of whether a particular
segment is incompetent.12
The aim of the present study was to correlate the
extent of histological changes in varicose veins with
mediators regulating the intrinsic and the extrinsic
pathways of apoptosis by detecting specific proe-
tins.11e16 We wished to evaluate these phenomena in
the saphenous trunks, major tributaries and accessory
veins. To find out whether apoptotic dysregulation
was a reversible process, we compared apoptotic cel-
lular regulation in the medial layer in the proximal
great saphenous veins in limbs previously stripped
of the distal saphenous trunk and tributaries as part
of varicose vein treatment.Material and Methods
The protocol for this study was considered by the lo-
cal committee on medical ethics and all patients in-
cluded in this work gave their informed written
consent.Cohort
In protocol 1, a total of 26 varicose veins were obtained
from 26 patients whowere undergoing lower-extremity
varicose vein surgery for primary varicose veins. The
characteristics of patients are given in Table 1. The oper-
ative indications classified according to the Clinical Eti-
ological Anatomical and Physiopathological (CEAP)Table 1. Characteristics of the 46 patients with healthy and pri-
mary varicose veins
Varicose veins
(n¼ 30)
Healthy veins
(n¼ 20)
Number of patients 26 20
Gender
Men: women 7: 19 6: 14
Mean age (years) 51 S.D. 9 58 S.D. 7
Height (cm) 167 S.D. 5 168 S.D. 6
Weight (kg) 76 S.D. 12 68 S.D. 13
Body mass index (BMI) 27 S.D. 6 24 S.D. 2
< 20 4 3
20e26 9 13
> 26 13 4
Clinical Etiological
Anatomical and Physiopathological classification:
Type 2 2 —
Type 3 21 —
Type 4 3 —
All data are expressed as means and SD.system as class 2 (n¼ 4), class 3 (n¼ 15) and class 4
(n¼ 7). Pre-operative duplex ultrasound confirmed
that the GSV was incompetent and had a diameter of
at least 5 mm. A total 20 healthy veins were obtained
from20patientswhowere undergoingdistal arterial by-
pass grafting surgery. Duplex ultrasonography con-
firmed that these veins were competent. For all the
venous specimens, the segment analyzed was the great
saphenous vein one centimetre distal to the sapheno-
femoral junction. In addition, the termination of the 3
principal tributaries of the GSV (anterior accessory sa-
phenousvein, superficial epigastric and external puden-
dal veins) were removed for analysis. Three accessory
veins were resected to analyse segments along the great
saphenous vein trunk in varicose and healthy veins.
In protocol 2, a total of 20 segments from varicose
veins were obtained from 20 patients previously oper-
ated upon for varicose veins. Operations had been
performed a mean of 4.6 S.D. 1.6 years previously
sparing the proximal part of the great saphenous
vein. Segments of residual GSV were obtained 1 cm
distally to the SFJ and were immuno-histochemically
analysed and compared with equivalent venous seg-
ments obtained from healthy patient group. A total
20 healthy veins were obtained from 20 patients
who were undergoing distal arterial bypass grafting
surgery.
Tissues specimens
All venous segments were fixed in 10% neutral
buffered formalin solution and paraffin embedded.
Vein specimens were sectioned (3 mm) (LEICA
JUNG-RM-2035) perpendicular to the axis of the ves-
sel, when the original venous segment was long
enough the whole block was sectioned and sections
were fixed each 5 mm (two to five sections per
block/slide).
Histology
Specimens were stained with haematoxylin and eosin
for routine histological evaluation. Trichrome staining
was used to assess vein wall collagen fibres. Victoria
blue was used to study elastin fibres. Results were
evaluated by two independent investigators who
were blinded to the patients’ clinical findings.Immunohistochemical detection
Cell apoptoses, mediators of the intrinsic mitochon-
drial and extrinsic trans membrane pathways were
detected with five primary antibodies: Apoptag per-
oxidase in situ Apoptosis Detection Kit e S7101Eur J Vasc Endovasc Surg Vol 35, February 2008
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rabbit polyclonal bax P-19 e SC526 (SANTA CRUZ
Biotechnology, INC) (diluted 1/40); rabbit polyclonal
antibody Caspase 9 Ab-4 (Cat RB-1205 e P1ABX)
(NEOMARKERS, Fremont, CA, USA) (diluted 1/40);
rabbit polyclonal antibody Fas Ab-2 (ONCOGENE,
code N AM01 L) (dilution 1/100); and polyclonal an-
tibody Caspase 8 Ab-4 (category RB-1200-P1ABX,
NEOMARKERS, Fremont, CA, USA) (dilution 1/40).
The immunohistochemical techniques used have
been detailed elsewhere.5
For the histological analysis four fields per section
were examined for staining at 400X magnification.
The immunohistochemical expression of apoptosis
was determined according to the intensity of nuclear
staining and the density and morphology of chroma-
tin. Results were evaluated by two independent inves-
tigators who were blinded to the patients’ clinical
findings. Peroxidase in situ, Bax, fas, caspase 8 and
9 -immunoreactive cells considered as positive for ap-
optosis in the medial layer were counted manually at
400X magnification and 5 random fields per section
were counted. Two to five sections per specimen
were evaluated. Immunohistochemical positive cell
staining was not investigated in the intima and
vasa-vasorum because previous studies found no dif-
ferences in intimal apoptosis in varicose and healthy
veins.3 Nor was positive cell staining investigated in
the adventitia because this layer is more severely
and diffusely disorganised and cell counts were thus
more approximate in varicose veins than in healthy
veins. The apoptotic index was calculated as the num-
ber of positive cells in each field divided by number
total of cells in the field multiplied by 100.Table 2. Immunohistochemical quantification of the specimens
from healthy and primary varicose veins
Number of positive Varicose veins Healthy veins *P valueStatistical analysis
All data are expressed as means and standard devia-
tion. Immunohistochemical results are expressed as
the apoptotic index for the five antibodies tested.
Data obtained were analyzed by the Mann-Whitney
test comparing the results obtained in the two groups.
A P value less than .05 was considered to be statisti-
cally significant. Statistical analyses were performed
with StatView (SAS Institute, Cart, NC, USA)
software.stained cells (in %)
Peroxidase in situ
apoptosis detection
2.6 S.D. 0.2 12 S.D. 0.9 .0001
Bax detection 2.1 S.D. 0.3 13 S.D. 0.9 .0001
Caspase 9 detection 3.2 S.D. 1 12 S.D. 1 .0001
Fas detection 11 S.D. 2 13 S.D. 2 .65
Caspase 8 detection 11 S.D. 1 10 S.D. 1 .61
All data are expressed as mean and SD. * Mann-Whitney test.Results
Histology standard
Varicose veins from the saphenous trunk, tributaries
and accessory veins exhibited severely disorganisedEur J Vasc Endovasc Surg Vol 35, February 2008parietal architecture. In trichrome-stained specimens,
the medial layer showed an increased number of col-
lagen fibres with a decrease in smooth muscular cells
in the sub-intimal layer. The total number of parietal
cells has not been compared between the two groups.
The adventitial layer was thinner in all varicose veins
(distal trunk, main branches and collaterals) than in
comparable healthy veins and contained more colla-
gen fibres. In Victoria blue stained specimens, the me-
dial layer consisted of elastin fibres constantly
fragmented with parcelled interruption of the internal
elastic lamina. The adventitial layer showed de-
creased density and size of elastin fibres and in-
creased fibre degradation.Immunohistochemical staining
PROTOCOL 1 (Table 2)
Peroxidase in situ apoptosis detection. Fig. 1(a and b)
Varicose veins arising in the trunk, main tributaries
and accessory veins contained fewer peroxidase in
situ-positive cells than comparable healthy veins. No
difference was found in the apoptotic index between
the saphenous trunk, main tributaries and accessory
veins (data not shown).
Bax detection. The apoptosis promoter index of
positive cell staining differed significantly in the two
groups: varicose veins from the saphenous trunk,
main tributaries and accessory veins contained fewer
Bax positive cells than healthy veins. No difference
was found in the Bax detection index between the sa-
phenous trunk, main tributaries and accessory veins
(data not shown).
Caspase 9 detection. Again, the apoptosis promoter
index of positive cell staining differed significantly in
the two groups: varicose veins with distal trunk,
main branches and collaterals mixed together con-
tained fewer caspase 9 positive cells than healthy veins
No difference was found in Caspase 9 detection index
between the saphenous distal trunk, main branches
and collaterals (data not shown).
Fig. 1. (a, b): Peroxidase in situ apoptosis detection showing
fewer peroxidase in situ-positive cells in varicose veins
(Fig. 1a) than in healthy veins (Fig. 1b) (original magnifica-
tion, X 400).
Table 3. Immunohistochemical quantification of the specimens
from healthy and previously treated varicose veins
Number of positive
stained cells (in %)
Varicose veins Healthy veins *P value
Peroxidase in situ
apoptosis detection
3.2 S.D. 0.61 11 S.D. 1.9 .0001
Bax detection 2.2 S.D. 0.3 12 S.D. 0.7 .0001
Caspase 9 detection 2.6 S.D. 0.6 12 S.D. 1.3 .0001
Fas detection 9.8 S.D. 2 10 S.D. 1 .4
Caspase 8 detection 10 S.D. 1 10 S.D. 1 .52
All data are expressed as mean and SD. * Mann-Whitney u test.
227Primary Varicose VeinsFas detection. There was no difference in the apo-
ptosis promoter index of positive cell staining for
Fas detection in the two groups: Fas immunoreactive
cells were found in similar numbers in varicose veins
with distal trunk, main branches and collaterals
mixed together and in healthy veins. No difference
was found in the Fas detection index for the saphe-
nous distal trunk, main branches and collaterals
(data not shown).
Caspase 8 detection. Again, there was no differ-
ence in the apoptosis promoter index of immunoreac-
tive cell staining for caspase 8 detection in the two
groups: similar numbers of caspase 8 immunoreactive
cells were detected in varicose veins with distal trunk,
main branches and collaterals mixed together and in
healthy veins. The Caspase 8 detection index was sim-
ilar in the saphenous distal trunk, main branches and
collaterals (data not shown).
PROTOCOL 2 (Table 3)
Peroxidase in situ apoptosis detection. The apoptotic
index of immunoreactive cell staining differedsignificantly in the two groups: the residual proximal
part of varicose veins contained fewer peroxidase in
situ-immunoreactive cells than comparable healthy
veins.
Bax detection. The apoptosis promoter index of im-
munoreactive cell staining also differed significantly
in the two groups: the residual proximal part of vari-
cose veins contained fewer Bax-immunoreactive cells
than healthy.
Caspase 9 detection. Again, the apoptosis pro-
moter index of positive cell staining differed signifi-
cantly in the two groups: residual proximal part of
varicose veins contained fewer caspase 9 positive cells
than healthy.
Fas detection. There was no difference in the apo-
ptosis promoter index of immunoreactive cell staining
for Fas detection in the two groups: the residual prox-
imal part of varicose veins and healthy veins con-
tained similar numbers of Fas immunoreactive cells.
Caspase 8 detection. Again, there was no differ-
ence in the apoptosis promoter index of immunoreac-
tive cell staining for caspase 8 detection in the two
groups: the residual proximal part of varicose veins
and healthy veins contained similar numbers of cas-
pase 8 immunoreactive.Discussion
We detected marked histological changes in the archi-
tectural organisation and distribution of collagen and
elastin fibres in varicose veins compared to control
veins, in agreement with other published work. We
also confirmed that immunoreactivity to apoptotic de-
tection was less prominent in the medial layer of var-
icose veins than in healthy veins. In varicose veins, we
found fewer specific mediators regulating the intrinsic
apoptosis pathway. These cellular findings corrobo-
rate our previous clinical studies suggesting deregu-
lated programmed cell death, acting through the
intrinsic mitochondrial apoptosis pathway promoter,
as a possible cause of primary varicose veins in hu-
mans.5,12 We found that the changes involved notEur J Vasc Endovasc Surg Vol 35, February 2008
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tributaries as well. Similar phenomena were present
in patients with primary varices and in those patients
who had previously undergone varicose vein surgery.
The diffusely disorganised architecture and distri-
bution of collagen and elastin fibres corresponds to
fibrotic degradation of the parietal wall previously
observed and a loss of mechanical properties in vari-
cose veins.3,17 Further studies are required to precisely
determine whether apoptotic dysregulation is related
to the global number of parietal cells observed in the
histological changes.
Apoptosis plays a major role in tissue homeostasis
and maintenance so the decreased cell turnover we
observed in all parts of the superficial venous system
could be a major determinant of the parietal weakness
in primary varicose veins. Deregulated apoptosis is
a fundamental mechanism in a variety of diseases
principally cancer, but also, autoimmune disorders,
immunodeficiency, inflammation, ischemic heart dis-
ease, stroke and neurodegenerative diseases.18e20 Al-
though less is known about cell turnover in the
vascular wall, recent evidence shows that apoptosis
is inversely correlated with re-stenosis related to arte-
rial intimal hyperplasia after angioplasty and venous
grafting.21,22 Our findings in varicose veins contrast
with the increased apoptosis and increased numbers
of intrinsic pathway promotors including the apopto-
tic promoter Bax reported by others in renal, coronary
and carotid artery specimens from patients with ad-
vanced atherosclerotic lesions.6
Our findings confirm that the process of pro-
grammed cell death is down-regulated in primary
varicose veins as suggested by other authors 13e15 A
previous study showed a decrease in the apoptotic in-
dex in the adventitia of varicose veins compared with
control veins and no difference in the media layer (as
in our study).13 These discrepancies presumably re-
flect the different tissues examined. Cell cultures
from varicose veins show that the main component
of the venous wall, smooth-muscle cells, principally
localised in the medial layer, transform from normally
contractile to secretory cell types thus leading to the
fibrotic nature of in the varicose vein wall.23 Cell cycle
changes in varicose veins mediate the smooth-muscle
cell dedifferentiation from a contractile to a secretory
phenotype.24 Fibrotic degradation seen in the varicose
venous wall is associated with dysregulation of apo-
ptosis owing to decreased turnover of smooth-muscle
cells in the media layer. The intrinsic pathway can be
induced by mitochondrial release of cytochrome c, in
response to various stimuli, including elevated levels
of the pore-forming pro-apoptotic Bcl-2 family, in-
cluding Bax. Within the cytosol, cytochrome c bindsEur J Vasc Endovasc Surg Vol 35, February 2008and activates Apaf-1, thus binding and activating
pro-caspase-9.25e27 Active caspase-9 serves as the api-
cal caspase of the intrinsic (mitochondrial) pathway,
and directly cleaves and activates the apoptotic effec-
tor protease, caspase-3.28,29
We studied a group of patients who had previously
undergone varicose vein surgery which preserved the
saphenous trunk. Findings in this group were identi-
cal to those in patients with primary varices. This sug-
gests that the abnormal apoptosis is irreversible once
it affects the venous system. However, our previously
operated group also had recurrent varices which
might have caused a return of the apoptotic malfunc-
tion. Our findings indicate that diseased veins may
extend beyond the clinically detectable limits of ve-
nous disease.
In conclusion, our results provide evidence of de-
creased programmed cell death in the medial layer
of human primary varicose veins. Assay of specific
proteins indicates that the physiological decrease in
normal apoptosis is modulated through the intrinsic
mitochondrial-dependent pathway. This observa-
tional study implicates apoptotic down-regulation in
the veins wall as a cause of varicose veins but does
not exclude the possibility that other mechanisms
are also responsible.References
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